Target intelligence / Profile preview

PH and SEC7 domain-containing protein 4 (PSD4)

Target
PSD4
Molecular classification
Guanine nucleotide exchange factor (GEF), Pleckstrin homology and Sec7 domain-containing protein
01

Overview

PH and SEC7 domain-containing protein 4 (PSD4) is a member of the guanine nucleotide exchange factor (GEF) family that specifically activates small GTPases in the ARF family, notably ARF6 and ARL14/ARF7[1]. The protein contains pleckstrin homology (PH) and Sec7 domains; the PH domain enables phospholipid binding, and the Sec7 domain confers GEF activity. Through activation of ARF6 and ARL14, PSD4 regulates signal transduction related to actin cytoskeleton remodeling and membrane recycling, especially in immune cells such as dendritic cells, by controlling movement of MHC class II vesicles. PSD4 is located primarily at ruffle membranes in cells, consistent with roles in dynamic membrane processes[1][3]. No approved drugs target this molecule, and no direct disease associations are high-confidence, although its molecular function suggests possible involvement in processes critical to immunity and cell trafficking.

Other names
PSD4Pleckstrin and Sec7 domain containing 4EFA6BExchange factor for ARF6 BTICADP-ribosylation factor guanine nucleotide-exchange factor 6BTelomeric of interleukin-1 cluster proteinSEC7 homolog
02

Mechanism of action

Not applicable (no drugs established yet). Putative mechanism for a hypothetical drug would be inhibition or modulation of GEF activity for ARF6/ARF7, affecting signal transduction and membrane trafficking

03

Biological functions

Guanyl-nucleotide exchange factor activity for ARF family small GTPases, particularly ARF6 and ARL14/ARF7Phospholipid bindingSignal transduction, particularly regulation of ARF protein signal transductionMembrane recyclingRegulation of vesicle movement along the cytoskeleton in dendritic cells (affecting MHC class II-containing vesicles)
04

Disease associations

Other (no direct high-confidence link to human diseases such as cancer or inflammation based on current curated resources, but possible relevance due to activity in membrane trafficking and immune cell functions)Potential role in immune response through control of vesicle trafficking in dendritic cells
05

Safety considerations

Not specifically described in the current literature.Since PSD4 regulates vesicle trafficking and ARF signaling, safety concerns may relate to disruption of immune cell function or membrane trafficking, but no established challenges for therapeutic modulation.

Beyond the preview

Go deeper on PH and SEC7 domain-containing protein 4 (PSD4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PH and SEC7 domain-containing protein 4 (PSD4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call